— Know what they know.
Not Investment Advice

BDSI NASDAQ

BioDelivery Sciences International, Inc.
1W: +0.0% 1M: +0.5% 3M: +81.5% 1Y: +49.5% 3Y: +10.9% 5Y: +197.3%
$5.59
Last traded 2022-03-31 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $577.1M mcap

📊 Key Metrics

TTM
$167M
Revenue
+6.5% YoY
$85M
Net Income
+230.1% YoY
$41M
Free Cash Flow
+64.3% YoY
84.0%
Gross Margin
21.0%
Op. Margin
148.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE57.3%
ROA30.1%
ROIC80.4%

Valuation

P/E6.8
P/B3.1
EV/EBITDA5.9

Leverage

Debt/Equity0.31
Current Ratio2.45
Interest Cov.5.0x

Quality Scores

Piotroski F6/9
Altman Z1.63
Beneish M-1.43

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms